Skip to main content
Log in

Advances and Controversies in Military Posttraumatic Stress Disorder Screening

  • Military Mental Health (CH Warner, Section Editor)
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

As the longest war in American history draws to a close, an unprecedented number of service members and veterans are seeking care for health challenges related to transitioning home and to civilian life. Congressionally mandated screening for mental health concerns in the Department of Defense (DoD), as well as screening efforts Veterans Affairs (VA) facilities, has been established with the goal of decreasing stigma and ensuring service members and veterans with depression and posttraumatic stress disorder (PTSD) receive needed treatment. Both the DoD and VA have also developed integrated behavioral health in primary-care based initiatives, which emphasize PTSD screening, treatment, and care coordination. This article discusses the rationale for population-level deployment-related mental health screening, recent changes to screening frequency, commonly used screening instruments such as the primary care PTSD screen (PC-PTSD), PTSD checklist (PCL), and Davidson Trauma Scale (DTS); as well as the strengths/limitations of each, and recommended cut-off scores based on expected PTSD prevalence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hoge C. Once a Warrior—Always a Warrior: Navigating the Transition from Combat to Home, Including Combat Stress, PTSD, and mTBI Guilford, CT. Globe Pequot Press; 2010.

  2. Kok B, Herrell R, Thomas J, Hoge C. Posttraumatic stress disorder associated with combat service in Iraq or Afghanistan: reconciling prevalence differences between studies. J Nerv Ment Dis. 2012;200(5):440–50. This article provides a meta-analysis of studies of PTSD prevalence associated with military service in Iraq and Afghanistan. It provides a good explanation for why prevalences have varied widely in different studies.

    Article  Google Scholar 

  3. Hoge C, Grossman S, Auchterlonie J, Riviere L, Milliken C, et al. PTSD Treatment for Soldiers After Combat Deployment: Low Utilization of Mental Health Care and Reasons for Dropout. Psychiatr Serv. 2014. doi:10.1176/appi.ps.201300307. This article provides data consistent with several studies in Veterans Health Administration facilities highlighting continued problems with low utilization of mental health services and reasons for dropping out of care. The paper provides data on reasons for drop-out and the authors argue that enhancing engagement in care is the most important factor in improving overall effectiveness of treatment.

    PubMed  Google Scholar 

  4. Miliken C, Auchterlonie J, Hoge C. Longitudinal Assessment of Mental Health Problems Among Active and Reserve Component Soldiers Returning From the Iraq War. JAMA. 2007;298(18):2141–8.

    Article  Google Scholar 

  5. Warner C, Appenzeller G, Grieger T, Belenkiy S, Breitbach J, et al. Importance of Anonymity to Encourage Honest Reporting in Mental Health Screening After Combat Deployment. Arch Gen Psychiatr. 2011;68(10):1065–71. This article highlights the problem with underreporting of mental health symptoms by service members on manditory deployment-related military screenings, as compared to data collected using anonymous surveys.

    Article  PubMed  Google Scholar 

  6. Hoge C, Auchterlonie J, Milliken C. Mental Health Problems, Use of Mental Health Services, and Attrition From Military Service After Returning From Deployment to Iraq or Afghanistan. JAMA. 2006;295:1023–32.

    Article  CAS  PubMed  Google Scholar 

  7. Brady K, Pearlstein T, Asnis G, Baker D, Rothbaum B, et al. Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder. JAMA. 2000;283(14):1837–44.

    Article  CAS  PubMed  Google Scholar 

  8. Davidson J, Baldwin D, Stein D, Kuper E, Benattia I, et al. Treatment of Posttraumtic Stress Disorder With Venlafaxine Extended Release: A 6-Month Randomized Controlled Trial. Arch Gen Psychiatry. 2006;63:1158–65.

    Article  CAS  PubMed  Google Scholar 

  9. Davidson J, Pearlstein T, Londborg P, Brady K, Rothbaum B, et al. Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study. Am J Psychiatry. 2001;158:1974–81.

    Article  CAS  PubMed  Google Scholar 

  10. Davidson J, Rothbaum B, van der Kolk B, Sikes C, Farfel G. Multicenter, Double-blind Comparison of Sertraline and Placebo in the Treatment of Posttraumatic Stress Disorder. Arch Gen Psychiatry. 2001;58:485–92.

    Article  CAS  PubMed  Google Scholar 

  11. GlaxoSmithKline. A Study of the Maintained Efficacy and Safety of Paroxetine Versus Placebo in the Long-Term Treatment of Posttraumatic Stress Disorder. Unpublished. 2001.

  12. Martenyi F, Brown E, Zhang H, Koke S, Prakash A. Fluoxetine v placebo in prevention of relapse in post-traumatic stress disorder. BJP. 2002;181:315–20.

    Article  Google Scholar 

  13. Martenyi F, Brown E, Zhang H, Prakash A, Koke S. Fluoxetine Versus Placebo in Posttraumatic Stress Disorder. J Clin Psychiatry. 2002;63(3):199–206.

    Article  CAS  PubMed  Google Scholar 

  14. Martenyi F, Soldatenkova V. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial. Eur Neuropsychopharmacol. 2006;16:340–9.

    Article  CAS  PubMed  Google Scholar 

  15. Raskin M, Peskind E, Kanter E, Petrie E, Radant A. Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study. Am J Psychiatry. 2003;160:371–3.

    Article  Google Scholar 

  16. Raskin M, Peterson K, Williams T, Hoff D, Hart K, et al. A Trial of Prazosin for Combat Trauma PTSD With Nightmares in Active-Duty Soldiers Returned From Iraq and Afghanistan. Am J Psychiatry. 2013;170:1003–10. This article is important from a pharmacotherapy standpoint in that it is the first demonstration of efficacy with twice daily prazosin dosing.

    Article  Google Scholar 

  17. Schneier F, Neria Y, Pavlicova M, Hembree E, Jung Suh E, et al. Combined Prolonged Exposure Therapy and Paroxetine for PTSD Related to the World Trade Center Attack: A Randomized Controlled Trial. Am J Psychiatry. 2012;169:80–8.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Shalev A, Freedman S, Peri T, Brandes D, Sahar T, Orr S. Prospective Study of Posttraumatic Stress Disorder and Depression Following Trauma. Am J Psychiatry. 1998;155:630–7.

    CAS  PubMed  Google Scholar 

  19. Shih R, Schell T, Hambarsoomian K, Marshall G, Belzberg H. Prevalence of PTSD and Major Depression Following Trauma-Center Hospitalization. J Trauma. 2010;69(6):1560–6.

    Article  PubMed Central  PubMed  Google Scholar 

  20. van der Kolk B, Spinazzola J, Blaustein M, Hopper J, Hopper E, et al. A Randomized Clinical Trial of Eye Movement Desensitization and Reprocessing (EMDR), Fluoxetine, and Pill Placebo in the Treatment of Posttraumatic Stress Disorder: Treatment Effects and Long-Term Maintenance. J Clin Psychiatry. 2007;68:37–46.

    Article  PubMed  Google Scholar 

  21. Hoge C, Terhakopian A, Castro C, Messer S, Engel C. Association of Posttraumatic Stress Disorder With Somatic Symptoms, Health Care Visits, and Absenteeism Among Iraq War Veterans. Am J Psychiatry. 2007;164:150–3.

    Article  PubMed  Google Scholar 

  22. Frierson R. Combat-Related Posttraumatic Stress Disorder and Criminal Responsibility Determinations in the Post-Iraq Era: A Review and Case Report. J Am Acad Psychiatry Law. 2013;41:79–84.

    PubMed  Google Scholar 

  23. Terhakopian A, Sinaii N, Engel C, Schnurr P, Hoge C. Estimating Population Prevalence of Posttraumatic Stress Disorder: An Example Using the PTSD Checklist. J Trauma Stress. 2008;21(3):290–300.

    Article  PubMed  Google Scholar 

  24. McDonald S, Beckham J, Morey R, Calhoun P. The validity and diagnostic efficiency of the Davidson Trauma Scale in military veterans who have served since September 11th, 2001. J Anxiety Disord. 2009;23:247–55.

    Article  PubMed Central  PubMed  Google Scholar 

  25. National Defense Authorization Act (NDAA), F.Y. 1998, H.R.1119, Section 765.

  26. Ronald W. Reagan National Defense Authorization Act (NDAA), F.Y. 2005, H.R. 4200, Section 723.

  27. National Defense Authorization Act (NDAA), F.Y. 2012, H.R. 4310, Sections 582 & 1212., U.S. Congress.

  28. Warner C, Appenzeller G, Parker J, Warner C, Hoge C. Effectiveness of Mental Health Screening and Coordination of In-Theater Care Prior to Deployment to Iraq: A Cohort Study. Am J Psychiatry. 2011;168:378–85. This article is important because it demonstrates the effectiveness of coordinating mental health services between the operational and homefront environments in addition to screening.

    Article  PubMed  Google Scholar 

  29. Engel C, Oxman T, Yamamato C, Gould D, Barry S, et al. RESPECT-Mil: Feasibility of a Systems-Level Coliaborative Care Approach to Depression and Post-Traumatic Stress Disorder in Military Primary Care. Mil Med. 2008;173(10):935–40.

    PubMed  Google Scholar 

  30. Oxman T. RESPECT.Mil: Behavioral Health Specialist Manual. In: Excellence RMCo, editor. 2008

  31. Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Initial Assessment. Institute of Medicine. National Academy of Sciences. 2012.

  32. Bliese P, Wrigh K, Adler A, Castro C, Hoge C, et al. Validating the Primary Care Posttraumatic Stress Disorder Screen and the Posttraumatic Stress Disorder Checklist With Soldiers Returning From Combat. J Consult Clin Psychol. 2008;76(2):272–81.

    Article  PubMed  Google Scholar 

  33. Prins A, Ouimette P, Kimerling R, Cameron R, Hugelshofer D. The primary care PTSD screen (PC-PTSD): Development and operating characteristics. Prim Care Psychiatry. 2004;9:9–14.

    Article  Google Scholar 

  34. Forbes D, Creamer M, Biddle D. The validity of the PTSD checklist as a measure of symptomatic change in combat-related PTSD. Behav Res Ther. 2001;39:977–86.

    Article  CAS  PubMed  Google Scholar 

  35. Dobie D, Kivlahan D, Maynard C, Bush K, McFall M. Screening for post-traumatic stress disorder in female Veteran's Affairs patients: validation of the PTSD checklist. Gen Hosp Psychiatry. 2002;24:367–74.

    Article  PubMed  Google Scholar 

  36. Blanchard E, Jones-Alexander J, Buckley T, Forneris C. Psychometric Properties of the PTSD Checklist (PCL). Behav Res Ther. 1996;34(8):669–73.

    Article  CAS  PubMed  Google Scholar 

  37. Cook J, Elhai J, Arean P. Psychometric Properties of the PTSD Checklist With Older Primary Care Patients. J Trauma Stress. 2005;18(4):371–6.

    Article  PubMed  Google Scholar 

  38. Passos R, Figueira I, Mendlowicz M, Moraes C, Coutinho E. Exploratory factor analysis of the Brazilian version of the Post-Traumatic Stress Disorder Checklist – Civilian Version (PCL-C). Rev Bras Psiquiatr. 2012;34:155–61.

    PubMed  Google Scholar 

  39. Semage S, Sivayogan S, Forbes D, O'Donnell M, Monaragala R, et al. Cross-cultural and factorial validity of PTSD check list - military version (PCL-M) in Sinhalese language. Eur J Psychotraumatol. 2013;4:19707.

    Article  Google Scholar 

  40. Monson C, Gradus J, Young-Xu Y, Schnurr P, Price J. Change in posttraumatic stress disorder symptoms: Do clinicians and patients agree? Psychol Assess. 2008;20(2):131–8.

    Article  PubMed  Google Scholar 

  41. Wilkins K, Lang A, Norman S. Synthesis of the Psychometric Properties of the PTSD Checklist (PCL) Military, Civilian, and Specific Versions. Depress Anxiety. 2011;28:596–606. This article is an excellent discussion of the strengths, weaknesses, and limitations of the PCL in its various forms.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Hoge C, Castro C, Messer S, McGurk D, Cotting D. Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care. N Engl J. 2004;351:13–22.

    Article  CAS  Google Scholar 

  43. Thomas J, Wilk J, Riviere L, McGurk D, Castro C. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Arch Gen Psychiatr. 2010;67(6):614–23.

    Article  PubMed  Google Scholar 

  44. Bodkin J. Is PTSD caused by traumatic stress? J Anxiety Disord. 2007;21:176–82.

    Article  PubMed  Google Scholar 

  45. McDonald S, Thompson N, Stratton K, Calhoun P, MIRECC W. Diagnostic accuracy of three scoring methods for the Davidson Trauma Scale among U.S. military Veterans. J Anxiety Disord. 2014;28(2):160–8.

    Article  PubMed  Google Scholar 

  46. Davidson J, Tharwani H, Connor K. Davidson Trauma Scale (DTS): Normative scores in the general population and effect sizes in placebo-controlled SSRI trials. Depress Anxiety. 2002;15(2):75–8.

    Article  PubMed  Google Scholar 

  47. Foa E, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale. Psychol Assess. 1997;9(4):445–51.

    Article  Google Scholar 

  48. Shoeb M, Weinstein H, Mollica R. The Harvard Trauma Questionnaire: Adapting a Cross-Cultural Instrument for Measuring Torture, Trauma, and Posttraumatic Stress Disorder in Iraqi Refugees. Int J Soc Psychiatry. 2007;53(5):447–63.

    Article  PubMed  Google Scholar 

  49. Zhang L, Li H, Benedek D, Li X, Ursano R. A strategy for the development of biomarker tests for PTSD. Med Hypotheses. 2009;73(3):404–9.

    Article  PubMed  Google Scholar 

  50. Su T, Zhang L, Chung M, Chen Y, Bi Y, Chou Y. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J Psychiatr Res. 2009;43(13):1078–85.

    Article  PubMed  Google Scholar 

  51. van Zuiden M, Geuze E, Willemen H, Vermetten E, Maas M, Heijnen C, et al. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am J Psychiatry. 2011;168(89–96):89.

    Article  PubMed  Google Scholar 

  52. von Känel R, Begré S, Abbas C, Saner H, Gander M, Schmid J. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation. 2009;17(1):39–46.

    Google Scholar 

  53. Heim C, Ehlert U, Hellhammer D. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25(1):35.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Daniel J. Lee, Christopher H. Warner, and Charles W. Hoge declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel J. Lee.

Additional information

This article is part of the Topical Collection on Military Mental Health

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, D.J., Warner, C.H. & Hoge, C.W. Advances and Controversies in Military Posttraumatic Stress Disorder Screening. Curr Psychiatry Rep 16, 467 (2014). https://doi.org/10.1007/s11920-014-0467-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11920-014-0467-7

Keywords

Navigation